3rd Quarter - Report

SPLITOAK STRATEGIES LLC for CARIS LIFE SCIENCES, INC.

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Continue access to molecular and advanced genomic testing via telehealth; HR 2407/S The Medicare Multi-Cancer Early Detection Screening Coverage Act

LobbyistCovered position, as disclosed
AMY JENSEN Special Assistant to the President for Legislative Affairs; Assistant to the Speaker for Policy; Legislative Assistant; Policy Analyst

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2407 (118th)

Medical/Disease Research/Clinical Labs MED

Ensuring access to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing; Use of real-world evidence in clinical trials and FDA review; Cancer Moonshot; FDA proposed regulation to provide oversight of diagnostic lab tests

LobbyistCovered position, as disclosed
AMY JENSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Providing an appropriate regulatory model for advanced genomic cancer testing

LobbyistCovered position, as disclosed
AMY JENSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.